Enhancing the Presentation and Evaluation of Cumulative Post-Marketing Safety Data: A Pilot Study

被引：0
|
作者：
Gilchrist, A.
Layton, D.
Fogg, C.
Shakir, S.
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Portsmouth, Hants, England
来源：
DRUG SAFETY | 2011年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
下载
收藏
页码：968 / 968
页数：1
相关论文
共 50 条
  • [1] Enhancing the Presentation and Evaluation of Cumulative Post-Marketing Safety Data; a Pilot Study
    Gilchrist, Anna
    Layton, Deborah
    Fogg, Carole
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S338 - S339
  • [2] Number Needed to Harm as a Tool for Post-Marketing Drug Safety Evaluation: a Pilot Study with Thiazolidinediones
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2015, 38 (10) : 1005 - 1006
  • [3] Post-marketing Study of Linagliptin: A Pilot Study
    Alves Gomes, Gabrielle Kefrem
    Pereira, Mariana Linhares
    Sanches, Cristina
    Baldoni, Andre Oliveira
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [4] Post-marketing Drug Safety Evaluation Using Data Mining Based on FAERS
    Duan, Rui
    Zhang, Xinyuan
    Du, Jingcheng
    Huang, Jing
    Tao, Cui
    Chen, Yong
    DATA MINING AND BIG DATA, DMBD 2017, 2017, 10387 : 379 - 389
  • [5] Eslicarbazepine acetate: update of post-marketing safety data
    Vieira, M.
    Gama, H.
    Graca, J.
    Costa, R.
    Sousa, R.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 773 - 773
  • [6] Post-marketing evaluation of the short term safety of COMVAX®
    Davis, RL
    Black, S
    Shinefield, H
    Mahoney, L
    Zavitkovsky, A
    Lewis, E
    Nikas, A
    Guess, H
    Coplan, P
    VACCINE, 2004, 22 (3-4) : 536 - 543
  • [7] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [8] The safety of risperidone: a post-marketing study on 7684 patients
    Mackay, FJ
    Wilton, LV
    Pearce, GL
    Freemantle, SN
    Mann, RD
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (06) : 413 - 418
  • [9] The safety of oseltamivir in pregnancy: an updated review of post-marketing data
    Wollenhaupt, Martina
    Chandrasekaran, Abhijeeth
    Tomianovic, Danitza
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (10) : 1035 - 1042
  • [10] POST-MARKETING EVALUATION OF DRUGS
    REMINGTON, RD
    DRUG THERAPY, 1977, 7 (09) : 59 - 61
12345